Buscar | AC Mingle

pritijain1999 agregó una foto Other
2026-10-09 05:28:38 -

GLP-1 Market: Emerging Therapeutic Innovations and Industry Outlook
The GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...

0 Commentarios 0 Acciones 15 Views 0 Vista previa

Please log in to like, share and comment!
Rutujad agregó una foto Other
2026-09-22 09:19:54 -

GLP-1 Agonists Weight Loss Drugs Market Demand for Convenient Treatment Options
The weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...

0 Commentarios 0 Acciones 278 Views 0 Vista previa

Please log in to like, share and comment!
Rutujad agregó una foto Other
2026-10-08 07:55:39 -

Pen Needles Market: Europe Maintains Leadership as Asia Pacific Accelerates
The pen needles market is increasingly being shaped by a simple healthcare priority: making injectable therapies easier and more comfortable to manage. As diabetes prevalence continues to rise and more patients administer medications at home, Pen Needles Market are becoming an important part of everyday disease management. The global market was valued at USD 4.8 billion in 2025 and is projected...

0 Commentarios 0 Acciones 18 Views 0 Vista previa

Please log in to like, share and comment!